ArticleJournal of clinical medicine2024

Longitudinal Measurements of Blood Biomarkers in Patients with Crohn's Disease or Ulcerative Colitis Treated with Infliximab: Only the Latest Values in the Induction Period Predict Treatment Failure.

Kim Oren Gradel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.